Works matching DE "CANGENE Corp."
Results: 7
Investigational Heptavalent Botulinum Antitoxin (HBAT) to Replace Licensed Botulinum Antitoxin AB and Investigational Botulinum Antitoxin E.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2010, v. 59, n. 10, p. 299
- Publication type:
- Article
FDA Approval of an Extended Period for Administering VariZIG for Postexposure Prophylaxis of Varicella.
- Published in:
- JAMA: Journal of the American Medical Association, 2012, v. 307, n. 24, p. 2579
- Publication type:
- Article
15 June News.
- Published in:
- Clinical Infectious Diseases, 2013, v. 56, n. 12, p. 1, doi. 10.1093/cid/cit242
- Publication type:
- Article
Pipeline preview.
- Published in:
- Formulary, 2007, v. 42, n. 4, p. 214
- Publication type:
- Article
Human immune globulin: intravascular haemolysis.
- Published in:
- WHO Drug Information, 2010, v. 24, n. 2, p. 106
- Publication type:
- Article
Updated Recommendations for Use of VariZIG -- United States, 2013.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2013, v. 62, n. 28, p. 574
- By:
- Publication type:
- Article
New Anthrax Treatment Approved.
- Published in:
- JAMA: Journal of the American Medical Association, 2015, v. 313, n. 17, p. 1704, doi. 10.1001/jama.2015.3713
- By:
- Publication type:
- Article